United Therapeutics Corporation (uthr)
UTHR Ownership
Institutional holdings, insider activity, and 13F data for United Therapeutics Corporation are premium features in Vest Terminal.
Ownership & insider analytics is available in Vest Terminal for Professional and Enterprise subscribers.
Start Free — open UTHR in Vest Terminal
Access live data, filings, ownership, and analysis for United Therapeutics Corporation.
United Therapeutics Corporation FAQ
What does United Therapeutics Corporation (UTHR) do?
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-fi…
What is UTHR's P/E ratio?
United Therapeutics Corporation has a trailing P/E of 17.38× based on publicly available market data.
Does UTHR pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is UTHR in?
United Therapeutics Corporation is classified in Healthcare (Drug Manufacturers - Specialty & Generic) on NMS.
What is UTHR's market capitalization?
Approximate market cap: $20.99B.
What are the main risks for UTHR?
Key risks include negative revenue growth, among factors on this page.
What are the strengths of UTHR?
Potential positives include earnings growth of 13.4% year-over-year, return on equity near 19.3% — efficient use of shareholder capital.
Where can I get analyst estimates for UTHR?
Public analyst price targets and consensus for United Therapeutics Corporation are on the free /stocks/uthr/estimates page. Deeper estimate history and models are available in Vest Terminal.